Selcukbiricik, F. Et Al. 2011. KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care , (Stockholm, Sweden).

Selcukbiricik, F., YILDIZ, Ö., Tural, D., ÖZTÜRK, M. T., Demir, G., Ozguroglu, M., ... ERDAMAR ÇETİN, A. S.(2011). KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab? . European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden

Selcukbiricik, F. Et Al. "KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?," European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden, 2011

Selcukbiricik, F. Et Al. "KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?." European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care , Stockholm, Sweden, 2011

Selcukbiricik, F. Et Al. (2011) . "KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?." European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care , Stockholm, Sweden.

@conferencepaper{conferencepaper, author={F. Selcukbiricik Et Al. }, title={KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?}, congress name={European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care}, city={Stockholm}, country={Sweden}, year={2011}}